{"public_id":"cl_8206008e33509c5511b5d5bf3f090a76","status":"active","superseded_by_public_id":null,"corpus_id":90269576,"text":"Targeting phosphatase of regenerating liver-3 and survivin is presented as a promising strategy to overcome radioresistance and increase radiotherapy efficacy.","confidence":0.9,"paper":{"corpus_id":90269576,"title":"Molecular effectors of radiation resistance in colorectal cancer","url":"https://sah.borca.ai/papers/90269576"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_479fd5ca6e9ca5bceebf7123a7a29e6d","name":"radioresistance","description":"Resistance of cancer cells or tumors to radiation treatment.","types":["treatment resistance"],"url":"https://sah.borca.ai/concepts/co_479fd5ca6e9ca5bceebf7123a7a29e6d"},{"public_id":"co_66a62c16f021806302fc8a32f65fa9c4","name":"survivin","description":"An inhibitor of apoptosis protein implicated in cancer progression and treatment resistance.","types":["protein"],"url":"https://sah.borca.ai/concepts/co_66a62c16f021806302fc8a32f65fa9c4"},{"public_id":"co_bd4fb4e032163fdd7be9a0a24a08ccc6","name":"phosphatase of regenerating liver-3","description":"A protein implicated in colorectal cancer progression and therapy resistance.","types":["protein"],"url":"https://sah.borca.ai/concepts/co_bd4fb4e032163fdd7be9a0a24a08ccc6"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_8206008e33509c5511b5d5bf3f090a76"}